This historical review describes evidence and treatment-guidance gaps in 2004. Its terminology and treatment discussion have not been updated to current mental-health or neurological guidance.
Can J Psychiatry. 2004 Mar;49(3):157-63
Feinstein A.
Department of Psychiatry, University of Toronto, Ontario
This review describes the many neuropsychiatric abnormalities associated with multiple sclerosis (MS).
These may be broadly divided into 2 categories: disorders of mood, affect, and behaviour and abnormalities affecting cognition.
With respect to the former, the epidemiology, phenomenology, and theories of etiology are described for the syndromes of depression, bipolar disorder, euphoria, pathological laughing and crying, and psychosis attributable to MS.
The section discussing cognition reviews the prevalence and nature of cognitive dysfunction, with an emphasis on abnormalities affecting multiple domains of memory, speed of information processing, and executive function.
The detection, natural history, and cerebral correlates of cognitive dysfunction are also discussed.
Finally, treatment pertaining to all these disorders is reviewed, with the observation that translational research has been found wanting when it comes to providing algorithms to guide clinicians.
Guidelines derived from general psychiatry still largely apply, although they may not always be most effective in patients with neurologic disorders.
The importance of future research addressing this imbalance is emphasized, for neuropsychiatric sequelae add significantly to the morbidity associated with MS.
Source details
Author: Feinstein A.
Archive capture: . This is not a medical review date.